Northern Trust
IMRX icon

Northern Trust’s Immuneering IMRX Stock Holding History

Northern Trust’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$620K Buy
117,666
+8,605
+8% +$44.1K ﹤0.01% 3526
2025
Q4 		$718K Buy
109,061
+17,021
+18% +$109K ﹤0.01% 3520
2025
Q3 		$644K Buy
92,040
+52,311
+132% +$271K ﹤0.01% 3564
2025
Q2 		$134K Hold
39,729
– – ﹤0.01% 4041
2025
Q1 		$60.4K Hold
39,729
– – ﹤0.01% 4204
2024
Q4 		$87.4K Hold
39,729
– – ﹤0.01% 4180
2024
Q3 		$98.9K Sell
39,729
-119,188
-75% -$173K ﹤0.01% 4059
2024
Q2 		$203K Sell
158,917
-17,088
-10% -$28.1K ﹤0.01% 3863
2024
Q1 		$509K Sell
176,005
-7,922
-4% -$44.4K ﹤0.01% 3560
2023
Q4 		$1.35M Sell
183,927
-1,531
-0.8% -$10.2K ﹤0.01% 3190
2023
Q3 		$1.42M Buy
185,458
+12,237
+7% +$112K ﹤0.01% 3117
2023
Q2 		$1.76M Buy
173,221
+135,921
+364% +$1.31M ﹤0.01% 3078
2023
Q1 		$362K Buy
37,300
+2,640
+8% +$15K ﹤0.01% 3587
2022
Q4 		$168K Hold
34,660
– – ﹤0.01% 3941
2022
Q3 		$496K Buy
34,660
+18,977
+121% +$151K ﹤0.01% 3511
2022
Q2 		$85K Sell
15,683
-127,875
-89% -$682K ﹤0.01% 4232
2022
Q1 		$929K Buy
143,558
+67,667
+89% +$650K ﹤0.01% 3450
2021
Q4 		$1.23M Buy
75,891
+3,279
+5% +$79.8K ﹤0.01% 3462
2021
Q3 		$1.93M Buy
+72,612
New +$1.95M ﹤0.01% 3309

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust's IMRX Position: Q1 2026 in Review

Northern Trust increased its Immuneering (IMRX) stake by 7.9% in Q1 2026, buying an estimated $44.1K and bringing the position to 117,666 shares worth $620K. The position accounts for ﹤0.01% of the portfolio, ranked #3526.

Northern Trust first reported a position in IMRX in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.93M in Q3 2021. 95 funds tracked by Wall St. Rank hold IMRX as of Q1 2026.

  • Northern Trust held 117,666 shares of Immuneering worth $620K as of Q1 2026.
  • Northern Trust bought 8,605 Immuneering shares in Q1 2026, an estimated $44.1K.
  • Immuneering made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3526 holding.
  • Northern Trust first reported a position in Immuneering in Q3 2021 and has held it in 19 quarters since.
  • Northern Trust's Immuneering position peaked at $1.93M in Q3 2021.
  • 95 funds tracked by Wall St. Rank held Immuneering as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.